← Alle mensen

LJ

Lixin Jiang

2 publicaties

PubMed → Google Scholar →

Publicaties op Oncologisch.com

Pathologic Response of Fase III Study: Perioperative Camrelizumab Plus Rivoceranib and Chemotherapy Versus Chemothera...
Journal of clinical oncology : official journal of the American Society of Clinical Oncology · 2025-02
Olverembatinib na falen van TKI's inclusief ponatinib of asciminib bij CML: fase II
JAMA oncology · 1 januari 2025